Skip to main content
AmigoFish

ASCO 2026 Plenary: SARC-041

From Two Onc Docs · · 11 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

This week’s episode will be focusing on an ASCO 2026 Plenary abstract, SARC 041. SARC041 is the first positive phase 3 randomized controlled trial of a CDK4/6 inhibitor in advanced dedifferentiated liposarcoma (DDLPS), demonstrating that abemaciclib significantly improves progression-free survival compared to placebo.

Back to Two Onc Docs · Report a problem